Latest News

October 5, 2021

A High-Risk, High-Reward Approach to ALS

Multidisciplinary group of U-M researchers will investigate environmental exposures, chosen as one of the first projects in a new NIH amyotrophic lateral sclerosis initiative.

September 1, 2021

NIH Awards $1.4 Million for Sleep and Dementia Research

Principal investigators Tiffany Braley MD, MS and Galit Levi Dunietz PhD, MPH were recently awarded $1.4M in new R01 funding by the National Institute on Aging to study unexplored pathways between obstructive sleep apnea (OSA), OSA treatment, and dementia risk in older women and men.

July 30, 2021

New Research Highlights Important Pathway for Drug Treatment in Alzheimer’s Disease, Parkinson’s Disease, and Frontotemporal Dementia

Ann Arbor, MI – The work of affiliates of the Michigan Alzheimer’s Disease Research Center captured the attention of the Journal of Biological Chemistry last week for their new findings which could change the trajectory of treatment for key neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, frontotemporal dementia and

June 2, 2021

How Long Do Deep Brain Stimulation Benefits Last?

Deep brain stimulation remained effective in Parkinson's disease patients more than 15 years after the device was implanted, and patients continued to demonstrate significant improvement in motor symptoms, a retrospective study showed.

Pages